Alabama · 2026 Regular Session · Bill
SB 351: Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
SB 351 is a bill introduced in the Alabama Senate on March 10, 2026. According to its official title, it concerns: Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded. Primary sponsor: April Weaver (Republican). Most recent recorded action (April 7, 2026): Currently Indefinitely Postponed.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Health
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| April Weaver | Primary sponsor | Republican | Senate | 14 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Currently Indefinitely Postponed
- Reported Out of Committee House of Origin
- Read for the Second Time and placed on the Calendar (Healthcare)
- Read for the first time and referred to the Senate Committee on Healthcare
- Pending Committee Action in House of Origin (Healthcare)